Multigenetic Pharmacogenomics-Guided Treatment vs Treatment As Usual Among Hospitalized Men With Schizophrenia: A Randomized Clinical Trial. Zhewei Kang et al. JAMA Netw Open 2023 10 (10) e2335518

https://phgkb.cdc.gov/PHGKB/phgHome.action?query=Schizophrenia&action=search&Mysubmit=Search From the abstract: "What is the therapeutic efficacy of multigenic pharmacogenomics–guided treatment in patients with schizophrenia? In this randomized clinical trial that included 210 Chinese Han men, patients treated with multigenetic pharmacogenomics–guided treatment had a greater symptom improvement than those treated with treatment as usual after a 6-week treatment, measured as the mean difference in percentage change of Positive and Negative Syndrome Scale score. Meaning Multigenetic pharmacogenomic testing can be an effective tool to guide the treatment of schizophrenia. "